Viewing Study NCT00157937



Ignite Creation Date: 2024-05-05 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00157937
Status: COMPLETED
Last Update Posted: 2022-02-14
First Post: 2005-09-07

Brief Title: A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics 0476-329
Sponsor: Organon and Co
Organization: Organon and Co

Study Overview

Official Title: A Randomized Open Label Cross-Over Study Comparing Effectiveness for the Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics
Status: COMPLETED
Status Verified Date: 2022-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Subjects have 8-week with montelukast sodium or comparator drug administration period 2-week wash-out period and 8-week comparator drug or the drug administration period with cross-over design for assessment of the drug efficacy safety and tolerability
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2005_069 None None None